Bibliographic record
Abstract
What Is the Reimbursement Recommendation for Daybue? Canada’s Drug Agency (CDA-AMC) recommends that Daybue not be reimbursed by public drug plans for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older and weighing at least 9 kg. Why Did CDA-AMC Make This Recommendation? Evidence from 1 clinical trial demonstrated that Daybue resulted in improvements in caregiver-reported behavioural symptoms of Rett syndrome and overall clinical improvement according to clinicians, when compared to placebo. Caregivers of patients with Rett syndrome identified a need for treatments that improve communication skills, motor skills, health-related quality of life (HRQoL), caregiver burden, and other conditions associated with Rett syndrome. However, based on the evidence reviewed in the initial meeting and the reconsideration meeting, the Canadian Drug Expert Committee (CDEC) could not determine if Daybue addresses these needs. The uncertainty was mainly due to a lack of information on whether the results were clinically meaningful, missing data in the study, and a lack of HRQoL data.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.001 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.001 | 0.002 |
| Insufficient payload (model declined to judge) | 0.017 | 0.003 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".